These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22161437)

  • 1. Sclerotherapy for lower limb telangiectasias.
    Schwartz L; Maxwell H
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008826. PubMed ID: 22161437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for telangiectasias and reticular veins.
    Nakano LC; Cacione DG; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012723. PubMed ID: 34637138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of telangiectasia: comparison of sclerosing agents.
    Carlin MC; Ratz JL
    J Dermatol Surg Oncol; 1987 Nov; 13(11):1181-4. PubMed ID: 3312331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
    McCoy S; Evans A; Spurrier N
    Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
    Rao J; Wildemore JK; Goldman MP
    Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol.
    Goldman MP
    Dermatol Surg; 2002 Jan; 28(1):52-5. PubMed ID: 11991271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
    Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
    Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
    Conrad P; Malouf GM; Stacey MC
    Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
    Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML
    Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy of telangiectasias: A prospective, randomized, comparative clinical trial of hypertonic glucose versus sodium tetradecyl sulfate.
    Bukina OV; Sinitsyn AA; Pelevin AV
    Vasc Med; 2021 Jun; 26(3):297-301. PubMed ID: 33733965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter.
    Sadick NS
    J Dermatol Surg Oncol; 1991 Jan; 17(1):65-70. PubMed ID: 1991883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low concentration of sodium tetradecyl sulfate and hypertonic glucose solution for the treatment of telangiectasia: A prospective randomized clinical trial.
    Bukina OV; Sinitsyn AA; Efremova OI; Pelevin AV
    Phlebology; 2023 Oct; 38(9):622-627. PubMed ID: 37519033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating telangiectasias: my method.
    Ferrara F; Ferrara G
    Minerva Cardioangiol; 2013 Apr; 61(2):221-7. PubMed ID: 23492605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
    Ravi M; Kate V; Ananthakrishnan N
    Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.